Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Banco de datos
Tipo del documento
Intervalo de año de publicación
1.
Maturitas ; 158: 37-39, 2022 04.
Artículo en Inglés | MEDLINE | ID: mdl-35241236

RESUMEN

Depression and selective serotonin reuptake inhibitors (SSRI) reduce bone mass and increase fracture risk. We analyzed the association between SSRI use and fractures development in nursing homes residents during a one-year prospective observational study. Sixty-four of the 800 participants developed a fracture during the one-year follow-up. Individuals who developed fractures used SSRIs more often than residents who did not (40.6% vs 28.7%, p =0.045). SSRIs were associated with fractures (adjusted OR 1.76, 95% CI 1.04 - 2.98, p = 0.036). A regular medication review should be performed to reduce inappropriate prescriptions and related adverse consequences.


Asunto(s)
Fracturas Óseas , Inhibidores Selectivos de la Recaptación de Serotonina , Anciano , Densidad Ósea , Fracturas Óseas/inducido químicamente , Fracturas Óseas/epidemiología , Humanos , Casas de Salud , Estudios Prospectivos , Inhibidores Selectivos de la Recaptación de Serotonina/efectos adversos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA